Novocure Limited (NVCR)
Novocure has a market cap or net worth of $8.54 billion. The enterprise value is $8.16 billion.
The latest earnings date was Thursday, July 28, 2022, before market open.
|Last Earnings Date||Jul 28, 2022|
Novocure has 107.67 million shares outstanding. The number of shares has increased by 1.10% in one year.
|Shares Change (YoY)||+1.10%|
|Shares Change (QoQ)||+0.42%|
|Owned by Insiders (%)||13.27%|
|Owned by Institutions (%)||78.11%|
|EV / Earnings||n/a|
|EV / Sales||14.97|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||338.98|
The company has a current ratio of 8.08, with a Debt / Equity ratio of 1.31.
|Debt / Equity||1.31|
|Debt / EBITDA||n/a|
|Debt / FCF||23.97|
Return on equity (ROE) is -16.00% and return on invested capital (ROIC) is -4.40%.
|Return on Equity (ROE)||-16.00%|
|Return on Assets (ROA)||-6.00%|
|Return on Capital (ROIC)||-4.40%|
|Revenue Per Employee||$467,208|
|Profits Per Employee||-$58,472|
In the past 12 months, Novocure has paid $6.26 million in taxes.
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -39.65% in the last 52 weeks. The beta is 0.87, so Novocure's price volatility has been lower than the market average.
|52-Week Price Change||-39.65%|
|50-Day Moving Average||74.47|
|200-Day Moving Average||75.42|
|Average Volume (30 Days)||634,445|
Short Selling Information
The latest short interest is 6.78 million, so 6.29% of the outstanding shares have been sold short.
|Short % of Shares Out||6.29%|
|Short % of Float||7.53%|
|Short Ratio (days to cover)||14.37|
In the last 12 months, Novocure had revenue of $545.23 million and -68.24 million in losses. Earnings per share was -$0.57.
|Earnings Per Share (EPS)||-$0.57|
The company has $949.27 million in cash and $577.22 million in debt, giving a net cash position of $372.04 million or $3.46 per share.
|Cash & Cash Equivalents||949.27M|
|Net Cash Per Share||$3.46|
|Book Value Per Share||4.10|
In the last 12 months, operating cash flow was $50.88 million and capital expenditures -$26.80 million, giving a free cash flow of $24.08 million.
|Operating Cash Flow||50.88M|
|Free Cash Flow||24.08M|
|FCF Per Share||$0.22|
Gross margin is 78.70%, with operating and profit margins of -9.88% and -12.52%.
Dividends & Yields
Novocure does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for Novocure is $96.14, which is 21.27% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||21.27%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|